A novel 1,25-dihydroxyvitamin D - Activin A pathway in human alveolar macrophages is dysfunctional in patients with pulmonary alveolar proteinosis (PAP)

Barbara P. Barna, Anagha Malur, Heidi Dalrymple, Reema Karnekar, Daniel A. Culver, Susamma Abraham, Ravinder Jit Singh, Donald Brescia, Mani S. Kavuru, Mary Jane Thomassen

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

We have shown that activin A, a cytokine implicated in regulating B-cell proliferation, is severely deficient in alveolar macrophages from patients with pulmonary alveolar proteinosis (PAP), an autoimmune disorder characterized by surfactant accumulation and neutralizing autoantibodies to granulocyte-macrophage colony stimulating factor. Mechanisms of activin regulation in alveolar macrophages are not well understood. Based on previous gene array results from PAP bronchoalveolar lavage cells suggesting deficiencies in vitamin D target genes, and on recent evidence of vitamin D receptor elements (VDREs) in the human activin A gene promoter, we investigated the effects of 1,25-dihydroxyvitamin D (vitamin D3) on activin A expression in alveolar macrophages from healthy individuals and PAP patients. Activin A expression was stimulated by LPS in cultures of either healthy control or PAP alveolar macrophages; in contrast, vitamin D3 increased activin A only in healthy controls but not in PAP. Compared to healthy controls, freshly obtained (uncultured) PAP alveolar macrophages displayed healthy intrinsic vitamin D receptor expression but deficient expression of vitamin D target genes, cathelicidin and thioredoxin interacting protein. PAP patients also demonstrated a relative insufficiency of circulating vitamin D. Investigation of activin A in murine alveolar macrophages confirmed a lack of functional response to vitamin D as anticipated since murine activin A does not contain VDREs. Results suggest that mechanisms of activin A deficiency in PAP alveolar macrophages may involve dysregulation of a novel species-specific vitamin D-activin A pathway.

Original languageEnglish (US)
Pages (from-to)56-62
Number of pages7
JournalAutoimmunity
Volume42
Issue number1
DOIs
StatePublished - 2009

Fingerprint

Pulmonary Alveolar Proteinosis
Alveolar Macrophages
Vitamin D
Calcitriol Receptors
Cholecalciferol
Genes
activin A
1,25-dihydroxyvitamin D
Activins
Thioredoxins
Vitamin D Deficiency
Bronchoalveolar Lavage
Granulocyte-Macrophage Colony-Stimulating Factor
Surface-Active Agents
Autoantibodies
B-Lymphocytes
Cell Proliferation
Cytokines

Keywords

  • Activin A
  • Alveolar macrophage
  • Cathelicidin
  • Vitamin D

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

A novel 1,25-dihydroxyvitamin D - Activin A pathway in human alveolar macrophages is dysfunctional in patients with pulmonary alveolar proteinosis (PAP). / Barna, Barbara P.; Malur, Anagha; Dalrymple, Heidi; Karnekar, Reema; Culver, Daniel A.; Abraham, Susamma; Singh, Ravinder Jit; Brescia, Donald; Kavuru, Mani S.; Thomassen, Mary Jane.

In: Autoimmunity, Vol. 42, No. 1, 2009, p. 56-62.

Research output: Contribution to journalArticle

Barna, BP, Malur, A, Dalrymple, H, Karnekar, R, Culver, DA, Abraham, S, Singh, RJ, Brescia, D, Kavuru, MS & Thomassen, MJ 2009, 'A novel 1,25-dihydroxyvitamin D - Activin A pathway in human alveolar macrophages is dysfunctional in patients with pulmonary alveolar proteinosis (PAP)', Autoimmunity, vol. 42, no. 1, pp. 56-62. https://doi.org/10.1080/08916930802316277
Barna, Barbara P. ; Malur, Anagha ; Dalrymple, Heidi ; Karnekar, Reema ; Culver, Daniel A. ; Abraham, Susamma ; Singh, Ravinder Jit ; Brescia, Donald ; Kavuru, Mani S. ; Thomassen, Mary Jane. / A novel 1,25-dihydroxyvitamin D - Activin A pathway in human alveolar macrophages is dysfunctional in patients with pulmonary alveolar proteinosis (PAP). In: Autoimmunity. 2009 ; Vol. 42, No. 1. pp. 56-62.
@article{a51054ef8ec54d66af88816da8d02069,
title = "A novel 1,25-dihydroxyvitamin D - Activin A pathway in human alveolar macrophages is dysfunctional in patients with pulmonary alveolar proteinosis (PAP)",
abstract = "We have shown that activin A, a cytokine implicated in regulating B-cell proliferation, is severely deficient in alveolar macrophages from patients with pulmonary alveolar proteinosis (PAP), an autoimmune disorder characterized by surfactant accumulation and neutralizing autoantibodies to granulocyte-macrophage colony stimulating factor. Mechanisms of activin regulation in alveolar macrophages are not well understood. Based on previous gene array results from PAP bronchoalveolar lavage cells suggesting deficiencies in vitamin D target genes, and on recent evidence of vitamin D receptor elements (VDREs) in the human activin A gene promoter, we investigated the effects of 1,25-dihydroxyvitamin D (vitamin D3) on activin A expression in alveolar macrophages from healthy individuals and PAP patients. Activin A expression was stimulated by LPS in cultures of either healthy control or PAP alveolar macrophages; in contrast, vitamin D3 increased activin A only in healthy controls but not in PAP. Compared to healthy controls, freshly obtained (uncultured) PAP alveolar macrophages displayed healthy intrinsic vitamin D receptor expression but deficient expression of vitamin D target genes, cathelicidin and thioredoxin interacting protein. PAP patients also demonstrated a relative insufficiency of circulating vitamin D. Investigation of activin A in murine alveolar macrophages confirmed a lack of functional response to vitamin D as anticipated since murine activin A does not contain VDREs. Results suggest that mechanisms of activin A deficiency in PAP alveolar macrophages may involve dysregulation of a novel species-specific vitamin D-activin A pathway.",
keywords = "Activin A, Alveolar macrophage, Cathelicidin, Vitamin D",
author = "Barna, {Barbara P.} and Anagha Malur and Heidi Dalrymple and Reema Karnekar and Culver, {Daniel A.} and Susamma Abraham and Singh, {Ravinder Jit} and Donald Brescia and Kavuru, {Mani S.} and Thomassen, {Mary Jane}",
year = "2009",
doi = "10.1080/08916930802316277",
language = "English (US)",
volume = "42",
pages = "56--62",
journal = "Autoimmunity",
issn = "0891-6934",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - A novel 1,25-dihydroxyvitamin D - Activin A pathway in human alveolar macrophages is dysfunctional in patients with pulmonary alveolar proteinosis (PAP)

AU - Barna, Barbara P.

AU - Malur, Anagha

AU - Dalrymple, Heidi

AU - Karnekar, Reema

AU - Culver, Daniel A.

AU - Abraham, Susamma

AU - Singh, Ravinder Jit

AU - Brescia, Donald

AU - Kavuru, Mani S.

AU - Thomassen, Mary Jane

PY - 2009

Y1 - 2009

N2 - We have shown that activin A, a cytokine implicated in regulating B-cell proliferation, is severely deficient in alveolar macrophages from patients with pulmonary alveolar proteinosis (PAP), an autoimmune disorder characterized by surfactant accumulation and neutralizing autoantibodies to granulocyte-macrophage colony stimulating factor. Mechanisms of activin regulation in alveolar macrophages are not well understood. Based on previous gene array results from PAP bronchoalveolar lavage cells suggesting deficiencies in vitamin D target genes, and on recent evidence of vitamin D receptor elements (VDREs) in the human activin A gene promoter, we investigated the effects of 1,25-dihydroxyvitamin D (vitamin D3) on activin A expression in alveolar macrophages from healthy individuals and PAP patients. Activin A expression was stimulated by LPS in cultures of either healthy control or PAP alveolar macrophages; in contrast, vitamin D3 increased activin A only in healthy controls but not in PAP. Compared to healthy controls, freshly obtained (uncultured) PAP alveolar macrophages displayed healthy intrinsic vitamin D receptor expression but deficient expression of vitamin D target genes, cathelicidin and thioredoxin interacting protein. PAP patients also demonstrated a relative insufficiency of circulating vitamin D. Investigation of activin A in murine alveolar macrophages confirmed a lack of functional response to vitamin D as anticipated since murine activin A does not contain VDREs. Results suggest that mechanisms of activin A deficiency in PAP alveolar macrophages may involve dysregulation of a novel species-specific vitamin D-activin A pathway.

AB - We have shown that activin A, a cytokine implicated in regulating B-cell proliferation, is severely deficient in alveolar macrophages from patients with pulmonary alveolar proteinosis (PAP), an autoimmune disorder characterized by surfactant accumulation and neutralizing autoantibodies to granulocyte-macrophage colony stimulating factor. Mechanisms of activin regulation in alveolar macrophages are not well understood. Based on previous gene array results from PAP bronchoalveolar lavage cells suggesting deficiencies in vitamin D target genes, and on recent evidence of vitamin D receptor elements (VDREs) in the human activin A gene promoter, we investigated the effects of 1,25-dihydroxyvitamin D (vitamin D3) on activin A expression in alveolar macrophages from healthy individuals and PAP patients. Activin A expression was stimulated by LPS in cultures of either healthy control or PAP alveolar macrophages; in contrast, vitamin D3 increased activin A only in healthy controls but not in PAP. Compared to healthy controls, freshly obtained (uncultured) PAP alveolar macrophages displayed healthy intrinsic vitamin D receptor expression but deficient expression of vitamin D target genes, cathelicidin and thioredoxin interacting protein. PAP patients also demonstrated a relative insufficiency of circulating vitamin D. Investigation of activin A in murine alveolar macrophages confirmed a lack of functional response to vitamin D as anticipated since murine activin A does not contain VDREs. Results suggest that mechanisms of activin A deficiency in PAP alveolar macrophages may involve dysregulation of a novel species-specific vitamin D-activin A pathway.

KW - Activin A

KW - Alveolar macrophage

KW - Cathelicidin

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=58149485204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149485204&partnerID=8YFLogxK

U2 - 10.1080/08916930802316277

DO - 10.1080/08916930802316277

M3 - Article

C2 - 18803071

AN - SCOPUS:58149485204

VL - 42

SP - 56

EP - 62

JO - Autoimmunity

JF - Autoimmunity

SN - 0891-6934

IS - 1

ER -